Tag: science

EarthDaily Achieves CEOS Analysis Ready Data (CEOS-ARD) Compliance

by jezzabellemente, posted in Uncategorized

Validation Confirms Science-Grade Integrity of the EarthDaily Constellation 

VANCOUVER, British Columbia and NEW YORK, March 13 (Bernama-GLOBE NEWSWIRE) — EarthDaily today announced that its data products have achieved CEOS Analysis Ready Data (CEOS-ARD) compliance, a globally recognized standard established by the Committee on Earth Observation Satellites (CEOS).

CEOS-ARD compliance confirms that EarthDaily data meet rigorous international requirements for radiometric calibration and geometric correction approaches, metadata completeness, and interoperability across time and datasets, enabling immediate quantitative analysis with minimal additional user processing.

Importantly, EarthDaily achieved CEOS-ARD compliance prior to full commercial availability of its complete constellation, a rare milestone for a commercial Earth observation system.

“This achievement validates the scientific foundation of our data,” said Don Osborne, Chief Executive Officer of EarthDaily. “We built the EarthDaily Constellation as a measurement system first. Daily coverage only matters if the data are stable, comparable, and trustworthy over time. CEOS-ARD compliance confirms we are delivering science-grade data at commercial scale.”

CEOS Analysis Ready Data standards are important to science mission interoperability and include a range of public government missions, including Sentinel and Landsat products. The framework was developed to address a persistent challenge in Earth observation: as global data volumes grow, users often lack the infrastructure and expertise required to process raw imagery for scientific and operational applications. Systematic provision of CEOS-ARD reduces that burden and supports more effective decision-making.

EarthDaily’s architecture was intentionally designed to ensure continuity with established scientific archives. Its radiometric calibration approach, spectral configuration, and geometric correction standards enable comparability and compatibility with Landsat and Sentinel data records. This design allows users to integrate EarthDaily data seamlessly into existing time-series analyses while benefiting from enhanced spectral diversity and daily revisit.

Compliance signals that EarthDaily delivers:

  • Science-grade radiometric and geometric correction
  • Interoperable datasets structured for robust time-series analysis
  • Immediate usability for advanced analytics and AI workflows
  • Reduced preprocessing burden and improved analytical reliability

The EarthDaily constellation was engineered around measurement integrity from inception. As highlighted in recent SpaceNews coverage examining the system’s development and on-orbit performance, the EarthDaily Constellation incorporates:

  • Rigorous radiometric calibration
  • Thermal characterization for spectral stability
  • Simultaneous collection across 22 spectral bands
  • Consistent local acquisition timing
  • Architecture aligned for interoperability with Landsat and Sentinel archives

These design principles ensure that EarthDaily data is globally consistent and scientifically reliable for long-term change detection.

With six additional satellites launching in May and continued expansion later this year, the EarthDaily Constellation will enter commercial operations in Summer 2026, delivering daily, consistent global coverage supported by CEOS-ARD compliant science-grade data.

This milestone reinforces EarthDaily’s position as a commercial provider bridging scientific rigor with scalable, AI-ready Earth observation infrastructure.

About EarthDaily

EarthDaily is a global Earth observation company focused on delivering science-grade data and analytics designed for broad-area change detection and decision-centric intelligence. With the upcoming launch of the EarthDaily Constellation, the company is building a foundation for daily, globally consistent Earth intelligence to support governments and enterprises operating in complex, high-impact environments.

To learn more, visit earthdaily.com and follow EarthDaily on LinkedIn (@EarthDaily) and X (@EarthDailyA).

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a00964c1-54f3-418d-800e-2c09394a2aa3


Contacts
Tanya Cross
Vice President, Global Marketing and Communications
EarthDaily
tanya.cross@earthdaily.com

Alliance Advisors IR
EarthDailyPR@allianceadvisors.com 

SOURCE: EarthDaily Analytics

Eyexora Establishes Co-Headquarters in Singapore to Accelerate Growth Across Asia-Pacific

by jezzabellemente, posted in Uncategorized

SINGAPORE, Nov 6 (Bernama-BUSINESS WIRE) — Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced the establishment of its co-headquarters in Singapore, marking a major milestone in the company’s global expansion and deepening its commitment to advancing eye health worldwide. Eyexora’s seed financing was led by ClavystBio, a global life sciences investor based in Singapore, and its initial programs have been in-licensed from the Singapore Eye Research Institute (SERI).

The new Singapore headquarters will serve as a gateway to Eyexora’s growing activities across the Asia-Pacific region, supporting clinical development, research collaborations, and regional partnerships. This expansion further strengthens Eyexora’s collaboration with the Singapore Eye Research Institute (SERI), a long-standing partner in ophthalmic innovation.

Eyexora’s Singapore operations will be instrumental in driving the company’s mission to develop transformative, accessible treatments for patients with vision-threatening diseases, while advancing scientific collaboration in one of the world’s most dynamic healthcare innovation hubs.

“Singapore has become a global center for ophthalmic research and innovation, and we are proud to deepen our presence here,” said Theresa Heah, M.D., M.B.A., Chief Executive Officer and Vice Chair of the Board, Eyexora. “This new co-headquarters positions Eyexora at the heart of Asia-Pacific’s biomedical ecosystem and strengthens our collaboration with SERI. Together, we are accelerating the development of breakthrough therapies that can improve vision and quality of life for patients around the world.”

“This milestone reflects our vision to build a truly global ophthalmic company,” said William J. Link, Ph.D, Chairman of the Board at Eyexora. “Singapore’s strong research infrastructure and commitment to innovation make it an ideal base for expanding Eyexora’s partnerships and advancing the next generation of eye care solutions.”

“Eyexora’s new co-headquarters are a testament to Singapore’s leadership in ophthalmology research and clinical delivery, and position as a global life sciences hub,” said Khoo Shih, Ph.D, CEO, ClavystBio. “At ClavystBio, we are excited to partner seasoned leaders like Theresa, William and their team to accelerate meaningful innovations and make global health impact.”

Last month Eyexora announced the launch of its second spoke company, Y.ora Vision, Inc., focused on developing next-generation ophthalmic medical devices for glaucoma. The company’s creation, complementing initial spoke company, Serenora Therapeutics, Inc., underscores Eyexora’s commitment to building a global ecosystem of specialized ventures that advance innovation across key therapeutic areas in ophthalmology.

Eyexora’s Singapore co-headquarters complements its U.S. base in New York, and will anchor the company’s Asia-Pacific operations, including clinical, scientific, and strategic functions, as it continues to grow its global footprint.

About Eyexora

Eyexora is a global ophthalmology company pioneering a hub-and-spoke model to accelerate innovation in eye care. By centralizing scientific, clinical, regulatory, and commercial expertise, Eyexora advances a diversified pipeline of therapies and devices through focused subsidiaries, to reduce risk, improve efficiency, and scale impact. Founded by leaders with decades of ophthalmology experience and a track record of more than 30 successful company and product launches, Eyexora partners with clinician-scientists and research institutes worldwide to bring transformative eye care solutions to patients faster and smarter. For more information, visit www.eyexora.com.

About ClavystBio

ClavystBio is a life sciences investor and venture builder established by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Asia. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing startups together, we foster a vibrant and supportive community. For more information, please visit https://www.clavystbio.com/ and follow us on LinkedIn.

About Singapore Eye Research Institute (SERI)

Established in 1997, SERI is Singapore’s national research institute for ophthalmic and vision research. SERI’s mission is to conduct high-impact eye research that prevents blindness, low vision, and major eye diseases common to Singaporeans and Asians. Over the last decade, SERI has conducted landmark research projects that have led to tangible outcomes, patient benefits, and success stories. It has paved the way for significant improvements in how eye diseases are treated and prevented, not just for Singaporeans or Asians, but on a global scale.

At its inception, SERI saw a national remit in ophthalmic and vision research, and till today, SERI ensures that its facilities and resources are open to researchers across Singapore so that the greatest benefit may be obtained from what is a relatively small clinical ophthalmology catchment area in Singapore.

SERI has grown from a founding team of five in 1997 to a faculty of more than 253 staff, encompassing clinician scientists, scientists, research fellows, PhD students and support staff. This makes SERI one of the largest research institutes in Singapore, as well as the largest eye research institute in the Asia Pacific region. SERI has also over 255 adjunct faculties from various eye departments, biomedical institutes, and tertiary centres in Singapore. SERI has published an impressive array of 5,942 scientific papers and has secured external peer-reviewed competitive grants worth more than $473 million. As of December 2024, SERI’s faculty has been awarded with more than 1,425 national and international prizes and filed 188 patents.

As the research institute of the SNEC, and directly affiliated to the Yong Loo Lin School of Medicine, National University of Singapore, as well as the Duke-NUS Medical School, SERI undertakes vision research in collaboration with local clinical ophthalmic centres and biomedical research institutions, as well as major eye centres and research institutes throughout the world.

SERI ranks first globally in terms of eye publications per capita, far ahead of the US, UK, and Japan. With its impressive publication track record, SERI is comparable to renowned eye institutes, both regionally and internationally. Please see www.seri.com.sg.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20251104717799/en/

Contact

Media Contact
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com

Source : Eyexora

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

by jezzabellemente, posted in Uncategorized

SOMERSET, N.J., June 12 (Bernama-GLOBE NEWSWIRE) — Spring Bio Solution, a global leader in the comparator sourcing and clinical trial supplies, has launched NCE Grid, the world’s first free NCE-1 intelligence platform – built to decode, centralize, and visualize Para IV and NCE-1 opportunities in real-time.

Until now, tracking NCE exclusivity expirations and Paragraph IV filings has been a fragmented, manual, and cumbersome process, lacking a centralized solution. Regulatory updates are scattered across various portals, intelligence is buried in siloed databases, and timelines are tracked using spreadsheets. The result? Competitive blind spots, misaligned R&D, and a race already lost before it begins.

For generic pharmaceutical companies aiming to be the “first to file,” intelligence gaps, scattered data, and missed timelines can result in lost exclusivity and millions in revenue.

NCE Grid changes that.

NCE Grid is the world’s first free tool to integrate every critical data point, including molecule, innovator name, NCE-1 date, revenue, therapeutic usage, expected sales growth, and CAGR% into one intuitive platform. With real-time visualizations and actionable insights, NCE Grid empowers strategy, regulatory, and portfolio teams to identify, prioritize, and act on first-to-file opportunities with clarity and speed.

“We created NCE Grid because we saw too many companies struggle with fragmented insights and missed opportunities,” said Salim Shaikh, Founder and CEO of Spring Bio Solution. “In a race where timing is everything, our platform brings clarity, speed, and a competitive edge to decision-makers. When you think Para IV, think NCE Grid — Your trusted guide for strategic drug development.” 

To learn more, visithttps://ncegrid.springbiosolution.com/

About Spring Bio Solution

Spring Bio Solution partners with CROs, pharmaceutical companies, and research institutions worldwide, offering reliable solutions for comparator sourcing and clinical trial supplies. With offices and WDL (wholesale Drug Distribution License) facilities across the USA, EU, Singapore, and India, and a robust network of 400+ distribution partners and 30+ innovators, Spring Bio Solution ensures timely and compliant access to critical drug supplies.

Trusted by over 600 clients and maintaining a 99.9% success rate for sourcing comparator drugs/ RLDs/ innovator samples, the company offers industry-leading cold chain capabilities, ranging from -60°C to ambient temperatures. Through its partnership with LSPedia, Spring Bio Solution also ensures full DSCSA compliance and end-to-end traceability.

With experience supporting over 1,000 clinical trials and more than 12,000 bioequivalence studies, Spring Bio Solution empowers sponsors to de-risk operations and accelerate drug development with confidence.

For media inquiries, please contact:

Navdeep Trivedi
Vice President & Head, Digital Marketing
Spring Bio Solution
navdeep.trivedi@springbiosolution.com

SOURCE: Spring Bio Solution PTE.LTD

Mary Kay Inc. Awards 10 Grants to Young Innovators at 2025 Regeneron International Science and Engineering Fair

by jezzabellemente, posted in Uncategorized
Kristin Dasaro, Director, Package Engineering and Sustainability at Mary Kay, greets Brazilian cancer researcher, Carolina de Araujo Pereira da Silva, who received back-to-back awards from Mary Kay for innovative findings in the malignancy of tumors. (Photo Credit: Mary Kay Inc.)

DALLAS, May 29 (Bernama-BUSINESS WIRE) — Mary Kay Inc., a global advocate for furthering young women’s education and encouraging youth to follow their STEM dreams, returned for a second year as a Special Awards Organization at the Regeneron International Science and Engineering Fair (Regeneron ISEF) in Columbus, Ohio. Ten grants totaling nearly $10,000 were awarded to standout high school-aged students excelling in innovative projects spanning topics from finding cures for cancers affecting women to sustainable packaging innovation and protecting our planet’s most valuable resources.

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20250528325390/en/

Each year, the event convenes nearly 2,000 participants representing more than 60 countries, with a total award pool offering over $9 million in awards and scholarships and invitations to corporate and academic events with elite global leaders in STEM.

Celebrating its 75th year, ISEF, a program of Society for Science, is the world’s largest pre-college global STEM competition. Through a global network of local, regional, and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately $9 million in awards and scholarships at the annual Regeneron ISEF.

“The ingenuity, passion, and innovation demonstrated by these young STEM leaders are awe-inspiring,” said Carrissa Dowdy, Manager of Product Formulation at Mary Kay. “Their work has the potential to transform industries, drive sustainable advancements, and accelerate major breakthroughs in fields like cancer research, material science, and environmental engineering. Mary Kay is proud to stand behind them as they shape the future of STEM.”

MEET THE STUDENT STEM LEADERS

1.Pragathi Kasani-Akula (GA, USA) Multi-Color Magneto-Fluorescent Nanoarchitectures for the Targeted Identification of Exosomes of Triple Negative Breast Cancer

2.Grace Liu (NY, USA) Evaluating Gender Disparities Due to Decision-Making Under Uncertainty in Entrepreneurship: A Panel Data Analysis

3.Alina Albeik (VA, USA) Implications of Resveratrol on Memory Retention in Dugesia tigrina

4.Kaili Tseng and Leila Gheysar (CA, USA) Bombyx mori Antimicrobial Peptides: A Novel and Sustainable Catalyst for Cancer Cell Growth Inhibition and Death

5.Elisabeth Fischermann and Tom Kressbach (Bavaria, Germany) On the Hunt for Free Radicals With a Blue Light Reaction

6.Ela Doruk Korkmaz (Istanbul, Turkey) Investigation of Potential Anti-Cancer Impacts of Coffee Bean-Derived Exosomes Through Anti-Proliferative and Apoptosis Inducing Effects on Melanoma Skin Cancer Cells via Mitogen-Activated Protein Kinase Signaling Pathway

7.Carolina de Araujo Pereira da Silva* (Rio de Janeiro, Brazil) Salinomycin as a Molecular Trojan Horse for Targeting Mn-Induced Malignancy in Aggressive Tumors

8.Sofia Nunes (Maranhao, Brazil) Formulation of Low-Cost Artificial Skin for Cellular Regeneration and Severe Burns Treatment

9.Margareth Ac-ac (Negros Oriental, Philippines) SKIMP: Artificial Intelligence- Convolutional Neural Network (CNN) Portable Skin Cancer Detection Device With Skin Cancer Notifier Python-Based Program

10.Kamila Rotger-Costas and Miranda Sanz-Alvarez (Guaynabo and Caguas, Puerto Rico) EcoReishiFlex: An Innovative Sustainable Biodegradable Plastic Alternative Made From Ganoderma lucidum (Reishi Fungi) Polysaccharides

*Carolina de Araujo Pereira da Silva is a two-time Mary Kay Young Women in STEM grant recipient for her outstanding contributions to the cancer research field. Her 2024 prize money was utilized toward furthering her presented project – Rock the Metals! Investigating Manganese as a Trigger of Malignancy and Metal Transporters as Targets in Cancer Treatment which elevated her 2025 award-winning submission.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn, or follow us on X.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20250528325390/en/

Contacts

Mary Kay Inc. Corporate Communications
newsroom.marykay.com
972.687.5332 or media@mkcorp.com 

Source: Mary Kay Inc.

–BERNAMA

MARY KAY INSPIRES FUTURE INNOVATORS: YOUNG WOMEN IN STEM ‘BLEND’ BEAUTY AND SCIENCE

by jezzabellemente, posted in Uncategorized

Lewisville High School students attend immersive STEM Day for hands-on learning

Students from Lewisville High School – Harmon Campus (Texas, U.S.A.) putting their knowledge to the test by creating their own Mary Kay® Unlimited Lip Gloss at Mary Kay’s global Richard R. Rogers Manufacturing and Research & Development Center (Photo Credit: Mary Kay Inc.)

DALLAS, Feb 12 (Bernama-BUSINESS WIRE) — Mary Kay Inc., a global leader in science, innovation, and furthering young women’s education marked the 10th anniversary of the International Day of Women and Girls in Science on February 11 with an exploratory event aimed to inspire the next generation of female STEM leaders. According to UNESCO, “Women make up only 35% of students enrolled in STEM-related fields of study in higher education” (UNESCO, 2020).

This press release features multimedia. View the full release here: 
https://www.businesswire.com/news/home/20250211969602/en/

Thirty students from Lewisville High School – Harmon Campus arrived at Mary Kay’s Richard R. Rogers Manufacturing / R&D Center (R3) in Lewisville, TX, where they were greeted with an inspiring welcome and personal STEM career journey from Nichole Jones-Dooley, Vice President of Manufacturing North America at Mary Kay. Students then embarked on a guided tour of the state-of-the-art facility, learning about the vastly diverse aspects of STEM-related career opportunities within the global beauty and manufacturing industry.

The highlight of the day was a Cosmetic Chemistry class and hands-on experiment led by Carissa Dowdy, Manager, Product Formulation at Mary Kay. Participants learned about the intricacies of building complex product formulations and the science behind popular beauty products. Students then put their knowledge to the test creating their own Mary Kay® Unlimited Lip Gloss. Before departing, students and Mary Kay STEM professionals shared an engaging lunch, discussing various career paths for women in STEM, personal aspirations, and how to better encourage and support young women pursuing careers in science and technology.

“Empowering and inspiring the next generation of female scientists and innovators is a winning formula ensuring women are more equally represented in the future of STEM,” said Dr. Lucy Gildea, Chief Brand and Scientific Officer at Mary Kay. “By giving them the tools and knowledge to explore STEM fields, we’re nurturing future leaders who will shape the beauty and STEM industries. Witnessing their curiosity take hold and the spark ignite as they imagine the possibilities of their future in STEM – it’s tremendous!”

Lewisville ISD has a long history of providing quality K-12 education to its diverse and growing communities providing academic excellence, renowned fine arts, storied athletic programs, and resources for more than 48,000 students across 69 sprawling campuses.

“At Lewisville High School, we’re committed to providing our students with real-world learning experiences that inspire their curiosity and foster their academic growth,” said Lindsay Ayers, Administrator of Business Partnerships at Lewisville ISD. “Partnering with Mary Kay gave our students a firsthand look at the endless possibilities in STEM fields and opened these young women’s minds to career opportunities they may not have considered. We are fortunate to have strong ties to global corporate partners in our local community serving our future STEM leaders.”

Boasting a 63% female, global R&D team, Mary Kay celebrates and encourages young women who are taking charge of their futures through leadership, innovation, and determination to excel in STEM fields. By offering continued support to young women in STEM areas, Mary Kay is continuing their mission to enrich the lives of women everywhere.

About Mary Kay

Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on X.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20250211969602/en/

Contact

Media Inquiries, please contact: 972-687-5332 or media@mkcorp.com

Source : Mary Kay Inc.

–BERNAMA